24 May 2019

Three researchers from RIMLS are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

We congratulate our researchers with this funding and wish them a lot of success with their great work.


Matthijs Jore, Dept. of Medical Microbiology, theme Infectious diseases and global health

Project: The malaria parasite’s fight against our immune system
Malaria is caused by unicellular parasites that are transmitted by mosquitoes. This research project studies at a molecular level how malaria parasites can evade the human immune system. The obtained insight will be used to develop novel drugs and vaccines against malaria.


Daniele Tauriello, Dept. of Cell Biology, theme Tumors of the digestive tract
Project: Restoring the immune system to prevent cancer from spreading
White blood cells can kill spreading cancer cells but are frequently sidelined by the tumour. The researchers will dissect this process of immune evasion in cultured minitumours to then block it in colon cancer in mice. With this treatment option, they may be able to prevent or cure metastasis.


Johannes Textor, Dept. of Tumor Immunology, theme Cancer development and immune defense
Project: How Intelligent is the Immune System?
Like our brain, our immune system can learn. The researchers will build computer models of the immune system and train these to recognize text and images to understand how the system learns, forgets, and gets confused. This will help to design therapies that use the immune system, such as vaccines.

 

Related news items


Radboud-led collaboration generates innovative candidate drug against malaria

19 September 2019

A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.

read more

Radboud university medical center opens first healthcare AI labs

19 September 2019

These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.

read more

Careful prescription of addictive painkillers still necessary

19 September 2019

Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.

read more

Exercising at home has a positive effect on Parkinson's patients

19 September 2019

In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.

read more

A personal touch of Kartika Hapsari

18 September 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.

read more

Healthy weight limits risk of dementia even in old age

17 September 2019

Even late in life it makes sense to maintain a healthy weight, and thus to limit the risk of cognitive decline.

read more